Testosterone Replacement Safety Gets FDA Panel Review As Lawsuits Pile Up
This article was originally published in The Pink Sheet Daily
Executive Summary
Two advisory committees will discuss appropriate population for testosterone treatment and potential for adverse cardiovascular outcomes; product liability suits have been consolidated in Illinois federal court.